EPITEP: Discard the Curative Causes of Late Onset Epilepsy: the Role of Brain 18F-FDG PET
Sponsor
Central Hospital, Nancy, France (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05831371
Collaborator
(none)
87
1
4
21.5
Study Details
Study Description
Brief Summary
Etiology and cognitive prognosis in late onset epilepsy differ from young adults epilepsy. At the epilepsy onset, this is crucial to detect potential curative/treatable brain disorders. After classical investigation including morphological brain imaging, EEG, clinical assessment, which added value may have brain FDG PET in the diagnosis and prognosis evaluation?
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
87 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Discard the Curative Causes of Late Onset Epilepsy: the Role of Brain 18F-FDG PET
Anticipated Study Start Date
:
May 2, 2023
Anticipated Primary Completion Date
:
Aug 2, 2023
Anticipated Study Completion Date
:
Sep 2, 2023
Outcome Measures
Primary Outcome Measures
- diagnostic performances [2 years after epilepsy onset]
sensibility, specificty, accurracy
Secondary Outcome Measures
- cognitive prognosis performances [2 years after epilepsy onset]
sensibility, specificty, accurracy
Eligibility Criteria
Criteria
Ages Eligible for Study:
60 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
late onset épilepsy patients without lesion
-
epilepsy followed at the CHRU Nancy france
Exclusion Criteria:
-
epilepsy explained by cortical lesion
-
severe psychiatric disorders
-
severe addiction (alcool, drugs)
-
no FDG TEP performed
-
no neuropsychological assessement after 2 years epilepsy onset
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | CHRU Nancy | Nancy | France | 54000 |
Sponsors and Collaborators
- Central Hospital, Nancy, France
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
TYVAERT Louise,
Pr,
Central Hospital, Nancy, France
ClinicalTrials.gov Identifier:
NCT05831371
Other Study ID Numbers:
- 2023PI065
First Posted:
Apr 26, 2023
Last Update Posted:
Apr 26, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by TYVAERT Louise,
Pr,
Central Hospital, Nancy, France
Additional relevant MeSH terms: